Brief: Onxeo Identifies Predictive Biomarkers For AsiDNA

Valerio Therapeutics SA

03/01/2019 17:03

Jan 3 (Reuters) - ONXEO SA  C4X.PA :
    * ONXEO ANNOUNCES IDENTIFICATION OF PREDICTIVE BIOMARKERS
FOR
ASIDNA™, ITS FIRST-IN-CLASS DNA DAMAGE RESPONSE INHIBITOR
    * BIOMARKERS CORRELATED TO TUMORAL SENSITIVITY TO ASIDNA™,
SUPPORTING PERSONALIZED MEDICINE APPROACHES
    * A SELECTION TOOL TO SCREEN PATIENTS IN FUTURE CLINICAL
DEVELOPMENT OF ASIDNA™ BASED ON THESE PREDICTIVE BIOMARKERS OF
RESPONSE

Source text for Eikon:  ID:nBw2zSXQla 
Further company coverage:  C4X.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))